Navigation Links
Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
Date:7/11/2012

ated several programmes looking at liver fibrosis and liver cancer in collaboration with Professor Schuppan and Professor Pinzani, two key opinion leaders in the field of liver disease. These collaborators are facilitating target selection and providing proof-of-concept experimental systems.

Lung projects

In addition to its Atu111 programme, Silence is looking to exploit DACC, its lung endothelium specific RNAi delivery system in other areas of lung disease and is therefore exploring several drug candidates in a variety of lung cancer models.

New delivery systems

Silence continues to work to both improve its existing, and develop, new RNAi delivery systems that target new cell types and organs.

Zamore Design Rules

Through its acquisition of Intradigm Corporation, Silence obtained exclusive licences to three Zamore patent families from the University of Massachusetts Medical School, where Philip D. Zamore, PhD is the co-director of the RNA Therapeutics Institute. Following a review of these licences, Silence has now decided that their high cost of maintenance is not warranted and has entered into discussion with the University of Massachusetts with a view to returning these rights.

Terms of the Subscription

The Company has today conditionally placed 840,000,000 Subscription Shares at 0.5 pence per share with existing and new investors to raise £4.2 million before expenses.  The Subscription is conditional, inter alia, upon the passing of the Resolutions 1 to 3 and 8 and 9 (as set out in the Notice of General Meeting), the Share Capital Reorganisation occurring and Admission.

Details of the Open Offer

Silence is proposing to raise up to £0.5 million (before expenses) pursuant to the Open Offer. The proposed Issue Price of 0.5 pence per Open Offer Share is the same price as the price at which the Subscription Shares are being issued.

The Open Offer is being made on a pre-
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
2. Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
3. Silence Therapeutics Additional Listing
4. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
5. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
6. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
7. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
8. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
9. United Therapeutics Announces Additional $100 Million Share Repurchase Program
10. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
11. ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Topricin Pain Relief and ... been listed among nationally recommended over-the-counter (OTC) health ... by "U.S. News" Health in collaboration with "Pharmacy ... “No. 1 Pharmacists Recommended designation” in the “Topical ... brands, and is the only homeopathic formula to ...
(Date:5/17/2013)... Atlanta, GA (PRWEB) May 17, 2013 ... Obstetrics, Gynecology, and Women’s Health at the Albert Einstein ... of Oncology at the Montefiore Medical Center. He ... Einstein Cancer Center and leads the Einstein Breast Cancer ... focused on translational breast cancer research. He also serves ...
(Date:5/17/2013)... Oven Industries Inc. announces a new temperature control ... many user-friendly benefits. Contained all in one enclosure, the ... self-contained temperature control system, which has its ... unique, as well as highly convenient for users. ... which allows the user to use the device wherever ...
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
Breaking Biology Technology:Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3New Temperature Control Products Announced by Oven Industries Inc. 2
... earnings from continued, operations of 165% and ... dollars., QUEBEC CITY, Aug. 7 /PRNewswire-FirstCall/ - ... manufacturer and marketer of,science-based and professionally endorsed products ... financial results for the second,quarter of 2008., ...
... first commercially achieved F.O.G. (fats, oils, grease) wastewater treatment system, ... Beach. , ... San Marcos, CA ... Systems, Inc __title__ Green Technology for the Hospitality Industry] announces ...
... Mass., Aug. 6 Inverness Medical,Innovations, Inc. (Amex: ... attend the,Canaccord Adams 28th Annual Growth Conference on ... Boston, Massachusetts. Jon Russell, Vice,President Finance, is scheduled ... be made available to the public through a ...
Cached Biology Technology:Atrium generates strong growth during the second quarter 2Atrium generates strong growth during the second quarter 3Atrium generates strong growth during the second quarter 4Atrium generates strong growth during the second quarter 5Atrium generates strong growth during the second quarter 6Atrium generates strong growth during the second quarter 7Grease Reduction System a Break Through in Truly "Green" Technology for Luxury Resort 2Grease Reduction System a Break Through in Truly "Green" Technology for Luxury Resort 3Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008 2
(Date:5/18/2013)... 18, 2013) Research presented today at Digestive Disease ... with findings about the impact of coffee on autoimmune ... While coffee consumption recently has been associated with reduced ... a few more cups of java each month also ... disease. Researchers at the Mayo Clinic, Rochester, MN, linked ...
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) explores ... and lifestyle. , Individuals suffering from Crohn,s ... fatigue and poor quality of life. These symptoms ... A randomized, double blind, placebo-controlled study found for ... to significant relief of these symptoms. , ...
(Date:5/18/2013)... increasing number of U.S. children are experiencing gastrointestinal ... research presented at Digestive Disease Week (DDW). ... the Cleveland Clinic Children,s Hospital found that obese ... compared to their lean counterparts. The pattern showed ... be correlated to potential complications associated with obesity, ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3
... song from a bird of the same species, a zebra finch ... a time, occasionally cocking its head but otherwise immobile. Once it ... routine. ( See video .) In a new study ... ribonucleic acid that appear to regulate protein production go up ...
... complex others manage without. Researchers at the University of ... body despite having no eyes at all. The study has ... National Academy of Sciences (PNAS). Most animals react ... seeing complex images so that they can function in their ...
... Biomechanical testing of the Lockheed Martin (NYSE: ... the U.S. Army Natick Soldier Research, Development and Engineering ... help shape future requirements for the HULC based on ... ) For seven weeks, U.S. Army warfighters ...
Cached Biology News:MicroRNAs in the songbird brain respond to new songs 2Lockheed Martin's HULC™ Robotic Exoskeleton Enters Biomechanical Testing at U.S. Army Natick Soldier Systems Center 2
A431 cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Madin-Darby bovine kidney (MDBK) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
... Explorer processes up to 48 lanes, 24 ... input can be from either slab gel ... primer chemistries. The detection parameters in Explorer ... analyst consistency. We have built Explorer ...
Molecular Biological Resources offers bulk quantities of existing protein products. Please see the Chimerx divisions website for existing products and contact lloconne@molbiores.com for pricing....
Biology Products: